Pyrophosphate-Enhanced Oxidase Activity of Cerium Oxide Nanoparticles for Colorimetric Detection of Nucleic Acids

In recent years, cerium oxide (CeO<sub>2</sub>) nanoparticles (NPs) have drawn significant attention owing to their intrinsic enzyme mimetic properties, which make them powerful tools for biomolecular detection. In this work, we evaluated the effect of pyrophosphate (PPi) on the oxidase...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seokhwan Kim, Jinjoo Han, Heeseok Chung, Yong-Keun Choi, Ayemeh Bagheri Hashkavayi, Yu Zhou, Ki Soo Park
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/7c45b5d480ed46edbe6b7eecc338ecfd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:In recent years, cerium oxide (CeO<sub>2</sub>) nanoparticles (NPs) have drawn significant attention owing to their intrinsic enzyme mimetic properties, which make them powerful tools for biomolecular detection. In this work, we evaluated the effect of pyrophosphate (PPi) on the oxidase activity of CeO<sub>2</sub> NPs. The presence of PPi was found to enhance the oxidase activity of CeO<sub>2</sub> NPs, with enhanced colorimetric signals. This particular effect was then used for the colorimetric detection of target nucleic acids. Overall, the PPi-enhanced colorimetric signals of CeO<sub>2</sub> NPs oxidase activity were suppressed by the presence of the target nucleic acids. Compared with previous studies using CeO<sub>2</sub> NPs only, our proposed system significantly improved the signal change (ca. 200%), leading to more sensitive and reproducible colorimetric analysis of target nucleic acids. As a proof-of-concept study, the proposed system was successfully applied to the highly selective and sensitive detection of polymerase chain reaction products derived from <i>Klebsiella pneumoniae.</i> Our findings will benefit the rapid detection of nucleic acid biomarkers (e.g., pathogenic bacterial DNA or RNA) in point-of-care settings.